Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription Articles published in Leuk Res Retrieve available abstracts of 325 articles: HTML format Text format

Single Articles

January 2012
1. CASTILLO JJ , Reagan JL, Ingham RR, Furman M, et al
   Obesity but not overweight increases the incidence and mortality of leukemia in adults: A meta-analysis of prospective cohort studies.
   Leuk Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. XING H , Yang X, Liu T, Lin J, et al
   The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.
   Leuk Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. HARDESTY BM , Cripe LD
   Cytarabine in relapsed acute myeloid leukemia.
   Leuk Res. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
4. VAN DER HAVE N , Nath SV, Story C, Tapp H, et al
   Differential diagnosis of paediatric bone pain: Acute lymphoblastic leukemia.
   Leuk Res. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
5. JAROSOVA M , Nedomova R, Hubacek J, Holzerova M, et al
   Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC).
   Leuk Res. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
6. LI X , Li J, Hu Y, Xie W, et al
   A comprehensive cytogenetic classification of 1466 Chinese patients with de novo acute lymphoblastic leukemia.
   Leuk Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. DE FIGUEIREDO AF , Vieira TP, Liehr T, Bhatt S, et al
   A rare cryptic and complex rearrangement leading to MLL-MLLT10 gene fusion masked by del(10)(p12) in a child with acute monoblastic leukemia (AML-M5).
   Leuk Res. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
8. BUCHI F , Spinelli E, Masala E, Gozzini A, et al
   Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine.
   Leuk Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. PUT N , Van Roosbroeck K, Broek IV, Michaux L, et al
   PDS5A, a novel translocation partner of MLL in acute myeloid leukemia.
   Leuk Res. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
10. YAMAMOTO K , Okamura A, Inui Y, Yakushijin K, et al
    A novel recurrent translocation t(7;17)(q22;p13) and a late-appearing t(2;3)(p13;q26.2) with dysmegakaryopoiesis in acute myeloid leukemia.
    Leuk Res. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
11. LOPOTOVA T , Nadvornikova S, Zackova M, Polak J, et al
    N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia.
    Leuk Res. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
12. ALONSO CN , Gallego MS, Rossi JG, Medina A, et al
    RT-PCR diagnosis of recurrent rearrangements in pediatric acute lymphoblastic leukemia in Argentina.
    Leuk Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GILES F , Rizzieri D, Ravandi F, Swords R, et al
    Elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia.
    Leuk Res. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
14. BROWN G , Hughes PJ, Ceredig R, Michell RH, et al
    Versatility and nuances of the architecture of haematopoiesis - Implications for the nature of leukaemia.
    Leuk Res. 2012;36:14-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. DUHOUX FP , Ameye G, Lambert C, Herman M, et al
    Novel head-to-head gene fusion of MLL with ZC3H13 in a JAK2 V617F-positive patient with essential thrombocythemia without blast cells.
    Leuk Res. 2012;36:e27-30.
    PubMed     Text format     Related articles   
    
    
    
    
16. NOVITZKY N , Thomas V
    In the absence of clinically significant graft vs. host disease, myeloablative conditioning may allow an effective graft vs. leukaemia effect.
    Leuk Res. 2012;36:104-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SAI S , Watanabe C, Okada S
    A rare case of childhood precursor B-cell lymphoblastic lymphoma in the mandible.
    Leuk Res. 2012;36:e37-8.
    PubMed     Text format     Related articles   
    
    
    
    
18. ORLANDI EM , Rocca B, Pazzano AS, Ghio S, et al
    Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia.
    Leuk Res. 2012;36:e4-6.
    PubMed     Text format     Related articles   
    
    
    
    
19. RAUH MJ , Rahman F, Good D, Silverman J, et al
    Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
    Leuk Res. 2012;36:81-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. MATHEW RA , Bennett JM, Liu JJ, Komrokji RS, et al
    Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.
    Leuk Res. 2012;36:72-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. BLACK JL , Litzow MR, Hogan WJ, O'Kane DJ, et al
    Correlation of CYP2B6, CYP2C19, ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patients.
    Leuk Res. 2012;36:59-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. HAFERLACH T , Bacher U, Alpermann T, Haferlach C, et al
    Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.
    Leuk Res. 2012;36:51-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
23. PAPPA V , Girkas K, Sambani C, Pagageorgiou S, et al
    Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: Outcomes of prolonged therapy.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
24. TANAKA Y , Manabe A, Nakadate H, Kondoh K, et al
    The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ROSSI G , Minervini MM, Carella AM, de Waure C, et al
    Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. SAVIC A , Kvrgic V, Rajic N, Urosevic I, et al
    The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. TRIFILIO SM , Rademaker AW, Newman D, Coyle K, et al
    Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KLIMEK VM , Dolezal EK, Smith L, Soff G, et al
    Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. SANCHEZ-GONZALEZ B , Penalver FJ, Medina A, Guillen H, et al
    Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. SUCH E , Cervera J, Ibanez M, Gomez-Segui I, et al
    Absence of mutations in the activation loop and juxtamembrane domains of VEGFR-1 and VEGFR-2 gene in chronic myelomonocytic leukemia (CMML).
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
31. YANG X , Liu S, Kharbanda S, Stone RM, et al
    AKT1 induces caspase-mediated cleavage of the CDK inhibitor p27Kip1 during cell cycle progression in leukemia cells transformed by FLT3-ITD.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. ZHANG C , Ryu YK, Chen TZ, Hall CP, et al
    Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. SHARMA SK , Sharma M, Seth T, Mishra P, et al
    Clinical profile and outcome of patients of acute myeloid leukemia with high hyperdiploidy.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
34. NAKATA J , Okada M, Tamaki H, Satake A, et al
    Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation.
    Leuk Res. 2011;35:1658-9.
    PubMed     Text format     Related articles   
    
    
    
    
35. SINGH H , Asali S, Werner LL, DeAngelo DJ, et al
    Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations.
    Leuk Res. 2011;35:1611-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
36. ALABSI AM , Ali R, Ideris A, Omar AR, et al
    Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. ABDELHAMID E , Preudhomme C, Helevaut N, Nibourel O, et al
    Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. BOONCHALERMVICHIAN C , Xie Y, Brynes RK, Siddiqi IN, et al
    Spontaneous, transient regression of B lymphoblastic leukemia in an adult patient: A variant presentation of prodromal/pre-ALL.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
39. BIERENBAUM J , Davidoff AJ, Ning Y, Tidwell ML, et al
    Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: A single-institution experience.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. DE OLIVEIRA JC , Scrideli CA, Brassesco MS, Morales AG, et al
    Differential MiRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. KOREN-MICHOWITZ M , Sato-Otsubo A, Nagler A, Haferlach T, et al
    Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysis.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. OTTONE T , Cicconi L, Hasan SK, Lavorgna S, et al
    Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
43. PASTORCZAK A , Gorniak P, Sherborne A, Hosking F, et al
    Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.
    Leuk Res. 2011;35:1534-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. HARROD R
    Inhibiting HDACs in a preclinical model of HTLV-1-induced adult T-cell lymphoma.
    Leuk Res. 2011;35:1436-7.
    PubMed     Text format     Related articles   
    
    
    
    
45. CRAIG BM , Rollison DE, List AF, Cogle CR, et al
    Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromes.
    Leuk Res. 2011;35:1453-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. BRECCIA M , Loglisci G, Cannella L, Serrao A, et al
    Nilotinib therapy does not induce consistent modifications of cholesterol metabolism resulting in clinical consequences.
    Leuk Res. 2011;35:e215-6.
    PubMed     Text format     Related articles   
    
    
    
    
47. SONTANI Y , Chapman G, Papathanasiou P, Dunwoodie S, et al
    Cooperation between somatic Ikaros and Notch1 mutations at the inception of T-ALL.
    Leuk Res. 2011;35:1512-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. ROSE C , Fournier M, Nibourel O, Herbaux C, et al
    Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy.
    Leuk Res. 2011;35:e203-5.
    PubMed     Text format     Related articles   
    
    
    
    
49. ZIMMERMAN B , Sargeant A, Landes K, Fernandez SA, et al
    Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma.
    Leuk Res. 2011;35:1491-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. KRISHNADAS DK , Stamer MM, Dunham K, Bao L, et al
    Wilms' tumor 1-specific cytotoxic T lymphocytes can be expanded from adult donors and cord blood.
    Leuk Res. 2011;35:1520-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. ISHIBASHI M , Tamura H, Ogata K
    Disease progression mechanism in myelodysplastic syndromes: insight into the role of the microenvironment.
    Leuk Res. 2011;35:1449-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
52. OZDEMIR N , Celkan T, Baris S, Batar B, et al
    DNA repair gene XPD and XRCC1 polymorphisms and the risk of febrile neutropenia and mucositis in children with leukemia and lymphoma.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. MOLICA S , Digiesi G, Antenucci A, Levato L, et al
    Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL).
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. AOKI J , Kakihana K, Kobayashi T, Hirashima Y, et al
    Tyrosine kinase inhibitor therapy for acute myeloid leukemia with late-appearing Philadelphia chromosome.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
55. TRASK PC , Cella D, Besson N, Kelly V, et al
    Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. KAMPEN KR
    The discovery and early understanding of leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. FAVREAU AJ , Sathyanarayana P
    miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. MORI M , Sprague J
    The successful remission induction by sorafenib and long-term complete remission in a FLT3-ITD-positive patient with a refractory acute erythroid leukemia and abnormal cytogenetics.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
59. CHOI Y , Yang Y, Beom SH, Park S, et al
    An unusually long survival without stem cell transplantation after the blast crisis phase of chronic myeloid leukemia: A case report.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
60. SANSONETTI A , Bourcier S, Durand L, Chomienne C, et al
    CD44 activation enhances acute monoblastic leukemia cell survival via Mcl-1 upregulation.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. DIAKIW SM , Kok CH, To LB, Lewis ID, et al
    The granulocyte-associated transcription factor Kruppel-like factor 5 is silenced by hypermethylation in acute myeloid leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. ZOU D , Yang X, Tan Y, Wang P, et al
    Regulation of the hematopoietic cell kinase (HCK) by PML/RARalpha and PU.1 in acute promyelocytic leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. ZOU YS , Ouahchi K, Lu Y, Liu W, et al
    Jumping translocations of 3q21 in an acute monocytic leukemia (M5) patient reveal mechanisms of multistage telomere shortening in pathogenesis of AML.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
64. STOETZER OJ
    Clomiphene treatment of acute myeloid leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
65. YOUNAN S , Elhoseiny S, Hammam A, Gawdat R, et al
    Role of Neuropilin-1 and its expression in Egyptian Acute Myeloid and Acute Lymphoid Leukemia patients.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. YOM-TOV G , Nathan I, Shpilberg O, Polliack A, et al
    Clomiphene as a novel modality for the treatment of acute myeloid leukemia: A pilot phase II study.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. ROCHOWSKI A , Rosenberg PS, Alonzo TA, Gerbing RB, et al
    Estimation of the prevalence of Fanconi anemia among patients with de novo acute myelogenous leukemia who have poor recovery from chemotherapy.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. GRAY JX , McMillen L, Mollee P, Paul S, et al
    WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. KOIVULA I , Juutilainen A
    Procalcitonin is a useful marker of infection in neutropenia.
    Leuk Res. 2011;35:1288-9.
    PubMed     Text format     Related articles   
    
    
    
    
70. HOLROYD A , Cross NC, Macdonald DH
    The two faces of myeloproliferative neoplasms: Molecular events underlying lymphoid transformation.
    Leuk Res. 2011;35:1279-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. STACCHINI A
    Flow cytometric detection of BCR-ABL in cerebrospinal fluid.
    Leuk Res. 2011;35:1286-7.
    PubMed     Text format     Related articles   
    
    
    
    
72. RAUW J , Wells RA, Chesney A, Reis M, et al
    Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
    Leuk Res. 2011;35:1335-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. WIKTOR AE , Van Dyke DL, Hodnefield JM, Eckel-Passow J, et al
    The significance of isolated Y chromosome loss in bone marrow metaphase cells from males over age 50 years.
    Leuk Res. 2011;35:1297-300.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. D'ALESSIO F , Mirabelli P, Mariotti E, Raia M, et al
    Miniaturized flow cytometry-based BCR-ABL immunoassay in detecting leptomeningeal disease.
    Leuk Res. 2011;35:1290-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
75. INTERMESOLI T , Castagnetti F, Soverini S, Bussini A, et al
    Durable molecular response despite F317L and E255K mutations: Successful treatment of chronic myeloid leukemia with sequential imatinib, nilotinib and dasatinib.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
76. GARDINER A , Parker H, Glide S, Mould S, et al
    A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. SCHOLL V , Hassan R, Zalcberg IR
    miRNA-451: A putative predictor marker of Imatinib therapy response in chronic myeloid leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
78. MACPHERSON GR , Hanson CA, Thompson DM, Perella CM, et al
    Retrovirus-transformed erythroleukemia cells induce central nervous system failure in a new syngeneic mouse model of meningeal leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. RICHARDSON RB
    Promotional etiology for common childhood acute lymphoblastic leukemia: The infective lymphoid recovery hypothesis.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. HOW GF , Muller MC, Lim LC
    Acquisition of the novel ABL kinase domain mutation T315L in a relapsed Philadelphia-positive acute lymphoblastic leukemia patient.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
81. KUHNL A , Kaiser M, Neumann M, Fransecky L, et al
    High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. TESFAI Y , Ford J, Carter KW, Firth MJ, et al
    Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. LATAGLIATA R , Breccia M, Castagnetti F, Stagno F, et al
    Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib.
    Leuk Res. 2011;35:1164-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. YU W , Wang J, Jin J, Qian W, et al
    Heat shock protein 90 inhibition results in altered downstream signaling of mutant KIT and exerts synergistic effects on Kasumi-1 cells when combining with histone deacetylase inhibitor.
    Leuk Res. 2011;35:1212-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. DUHOUX FP , Ameye G, Libouton JM, Bahloula K, et al
    The t(11;19)(q23;p13) fusing MLL with MYO1F is recurrent in infant acute myeloid leukemias.
    Leuk Res. 2011;35:e171-2.
    PubMed     Text format     Related articles   
    
    
    
    
86. YIN B
    PRAME: from diagnostic marker and tumor antigen to promising target of RNAi therapy in leukemic cells.
    Leuk Res. 2011;35:1159-60.
    PubMed     Text format     Related articles   
    
    
    
    
87. KIM YR , Kim MS, Lee SH, Yoo NJ, et al
    Mutational analysis of RUNX1T1 gene in acute leukemias, breast and lung carcinomas.
    Leuk Res. 2011;35:e157-8.
    PubMed     Text format     Related articles   
    
    
    
    
88. TANAKA N , Wang YH, Shiseki M, Takanashi M, et al
    Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells.
    Leuk Res. 2011;35:1219-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. SHIBATA M , Ezoe S, Oritani K, Matsui K, et al
    Predictability of the response to tyrosine kinase inhibitors via in vitro analysis of Bcr-Abl phosphorylation.
    Leuk Res. 2011;35:1205-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. BRECCIA M , Alimena G
    Nilotinib and dasatinib first-line: are we ready for imatinib replacement?
    Leuk Res. 2011;35:1153-5.
    PubMed     Text format     Related articles   
    
    
    
    
91. SANCHEZ-GUIJO FM , Duran S, Galende J, Boque C, et al
    Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study.
    Leuk Res. 2011;35:1184-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
92. MAURO FR , Bandini G, Barosi G, Billio A, et al
    SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. KUSNIERCZYK P , Giebel S, Nowak I
    Association of KIR2DS4 gene with susceptibility to leukemia: Chinese-Polish discrepancy.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
94. CHIARETTI A , Ruggiero A, Coccia P, Antonelli A, et al
    Expression of liquoral neuroprotection markers in children with acute lymphoblastic leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. ZHANG MY , Chen FY, Zhong H
    Meta-analysis of human leukocyte antigen genetic polymorphisms and susceptibility to chronic myelogenous leukemia in Chinese population.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. HAMBLIN TJ
    Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. NAUGLER C
    Human leukocyte antigen polymorphisms and leukemia susceptibility.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
98. GAC AC , Parienti JJ, Chantepie S, Fradin S, et al
    Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. SAROVA I , Brezinova J, Zemanova Z, Gancarcikova M, et al
    A novel gene LRP5 on 11q13.2 is rearranged in two patients with acute myeloid leukemia.
    Leuk Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
100. FIRTINA S , Sayitoglu M, Hatirnaz O, Erbilgin Y, et al
     Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. BROOME HE , Rassenti LZ, Wang HY, Meyer LM, et al
     ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. KUENDGEN A
     An inexpensive way to treat elderly patients with high-risk MDS or AML.
     Leuk Res. 2011;35:985-6.
     PubMed     Text format     Related articles   
     
     
     
     July 2011
103. YAMAMOTO K , Yakushijin K, Funakoshi Y, Inui Y, et al
     Biallelic ETV6 rearrangements by recurrent translocations t(7;12)(p15;p13) and t(3;12)(q26.2;p13) in acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
104. GIANNAKOULAS NC , Terpos E, Palassopoulou M, Zolota V, et al
     Increased RANKL and IL-6 levels might result in high bone turnover in a case of a CD34(+)/CD117(+)/myeloperoxidase(+dim) acute myeloid leukemia presenting with severe hypercalcemia and lumbar spine fractures.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
105. BRUSERUD O , Hatfield KJ, Reikvam H
     Heat shock protein 90 (HSP90) inhibition in acute myeloid leukemia-Targeting of disease heterogeneity through direct and indirect antileukemic effects.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
106. WANG YR , Jin RM, Xu JW, Zhang ZQ, et al
     A report about treatment refusal and abandonment in children with acute lymphoblastic leukemia in China, 1997-2007.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. YOON JY , Kumar R, Aloyz R, Johnston JB, et al
     Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
108. SINGH A , Jayanthan A, Farran A, Elwi AN, et al
     Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. SAI S , Nakagawa Y, Yamaguchi R, Suzuki M, et al
     Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. ALBANO F , Anelli L, Zagaria A, Coccaro N, et al
     Decreased TET2 gene expression during chronic myeloid leukemia progression.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. SAITO S , Matsuda K, Taira C, Sano K, et al
     Genetic analysis of TP53 in childhood myelodysplastic syndrome and juvenile myelomonocytic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. GAO W , Chang G, Wang J, Jin W, et al
     Inhibition of K562 leukemia angiogenesis and growth by selective Na(+)/H(+) exchanger inhibitor cariporide through down-regulation of pro-angiogenesis factor VEGF.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. CHOI MS , Lim JY, Cho BS, Kim YJ, et al
     The role of regulatory T cells during the attenuation of graft-versus-leukemia activity following donor leukocyte infusion in mice.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. STEIN BL , Smith BD
     Advanced age and prognosis in chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
115. WANG H , Chen XY, Wang BS, Rong ZX, et al
     The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: A meta-analysis.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. SORIANI S , Fedeli F, Molteni A, Grillo G, et al
     Three copies of isochromosome 8q in Ph+ B-cell acute lymphoblastic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
117. KREITMAN RJ
     Synergistic targeting of leukemia with leukotoxin and chemotherapy.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
118. DONAHUE AC , Abdool AK, Gaur R, Wohlgemuth JG, et al
     Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. SOVERINI S , Gnani A, De Benedittis C, Castagnetti F, et al
     Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. SUN J , McKallip RJ
     Plumbagin treatment leads to apoptosis in human K562 leukemia cells through increased ROS and elevated TRAIL receptor expression.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. GUILLEM V , Amat P, Cervantes F, Alvarez-Larran A, et al
     Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. GAO XN , Lin J, Gao L, Li YH, et al
     MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. NOFRINI V , Berchicci L, La Starza R, Gorello P, et al
     MN1-ETV6 fusion gene arising from MDS with 5q-.
     Leuk Res. 2011;35:e123-6.
     PubMed     Text format     Related articles   
     
     
     
     
124. KARP JE , Rassool FV
     KLFs and ATRA-induced differentiation: new pathways for exploitation.
     Leuk Res. 2011;35:846-7.
     PubMed     Text format     Related articles   
     
     
     
     
125. PETERSON EA , Gerrie AS, Power MM, Poulin MP, et al
     Disseminated mucormycosis presenting as transplant-associated thrombotic microangiopathy.
     Leuk Res. 2011;35:e138-40.
     PubMed     Text format     Related articles   
     
     
     
     
126. MORAVCOVA J , Rulcova-Karavdic J, Brouckova A, Klamova H, et al
     Effect of the duration and quality of peripheral blood sample storage on the results of qualitative and quantitative BCR-ABL transcript analyses in patients with CML.
     Leuk Res. 2011;35:e121-2.
     PubMed     Text format     Related articles   
     
     
     
     
127. OYEKUNLE AA , Castagnetti F, Gugliotta G, Soverini S, et al
     F317L BCR-ABL1 kinase domain mutation associated with a sustained major molecular response in a CML patient on dasatinib.
     Leuk Res. 2011;35:e118-20.
     PubMed     Text format     Related articles   
     
     
     
     
128. HASHMI S , Becker M
     Is consolidation chemotherapy necessary before non-myeloablative transplantation in AML?
     Leuk Res. 2011;35:841-3.
     PubMed     Text format     Related articles   
     
     
     
     
129. FRERET M , Gouel F, Buquet C, Legrand E, et al
     Rac-1 GTPase controls the capacity of human leukaemic lymphoblasts to migrate on fibronectin in response to SDF-1alpha (CXCL12).
     Leuk Res. 2011;35:971-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. DUHOUX FP , Auger N, De Wilde S, Wittnebel S, et al
     The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.
     Leuk Res. 2011;35:e114-7.
     PubMed     Text format     Related articles   
     
     
     
     
131. BUCHI F , Pastorelli R, Ferrari G, Spinelli E, et al
     Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.
     Leuk Res. 2011;35:921-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. ESKELUND CW , Nederby L, Thysen AH, Skovbo A, et al
     Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia.
     Leuk Res. 2011;35:914-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2011
133. PARK SH , Chi HS, Min SK, Park BG, et al
     Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. EL-MESALLAMY HO , Hegab HM, Kamal AM
     Expression of inhibitor of apoptosis protein (IAP) livin/BIRC7 in acute leukemia in adults: Correlation with prognostic factors and outcome.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. JIAO Y , Cui L, Gao C, Li W, et al
     CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. GUO QY , Chen BG, Ruan YY, Lin A, et al
     HLA-G expression is irrelevant to prognosis in patients with acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. KNOEBEL RW , McQuary A, Becker P, Hendrie P, et al
     Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+cytarabine.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
138. VILLA O , Mallo M, Kosyakova N, Salido M, et al
     Deletion of TET2 gene in an acute myeloid leukemia case with a t(4;15)(q24;q26) characterized by glass needle based chromosome microdissection and oligonucleotide array.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
139. PODESTA JE , Sugar R, Squires M, Linardopoulos S, et al
     Adaptation of the plasma inhibitory activity assay to detect Aurora, ABL and FLT3 kinase inhibition by AT9283 in pediatric leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. GUPTA A , Le A, Belinka BA, Kachlany SC, et al
     In vitro synergism between LFA-1 targeting leukotoxin (Leukothera) and standard chemotherapeutic agents in leukemia cells.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. RASI S , Bruscaggin A, Rinaldi A, Cresta S, et al
     Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. CHAGAN-YASUTAN H , Tsukasaki K, Takahashi Y, Oguma S, et al
     Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. LANGABEER SE , McCarron SL, Carroll P, Kelly J, et al
     Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
144. ZAMECNIKOVA A
     Chromosomal translocation t(1;9)(q24;q34) in acute lymphoblastic leukemia patient involving the ABL1 gene.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
145. CAMPBELL PK , Zong Y, Yang S, Zhou S, et al
     Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2011
146. WAKIM JJ , Tirado CA, Chen W, Collins R, et al
     t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: Report of a case treated with sorafenib and review of the literature.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
147. ATFY M , Al Azizi NM, Elnaggar AM
     Incidence of Philadelphia-chromosome in acute myelogenous leukemia and biphenotypic acute leukemia patients: And its role in their outcome.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. ESKAZAN AE , Soysal T, Erbilgin Y, Ozbek U, et al
     Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients?
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
149. PARK SH , Min SK, Park BG, Jang S, et al
     Clinical usefulness of plasma specimens for detection of nucleophosmin 1 gene mutations in patients with normal karyotype acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
150. MELESHKO AN , Savva NN, Fedasenka UU, Romancova AS, et al
     Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. KUDO K , Terui K, Sasaki S, Kamio T, et al
     CD7-positive acute myelomonocytic leukemia with trisomy 21 as a sole acquired chromosomal abnormality in two adolescents.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
152. TAKEUCHI S , Matsushita M, Zimmermann M, Ikezoe T, et al
     Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. NISHIO N , Takahashi Y, Tanaka M, Xu Y, et al
     Aberrant phosphorylation of STAT5 by granulocyte-macrophage colony-stimulating factor in infant cytomegalovirus infection mimicking juvenile myelomonocytic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. MESSMER BT , Nour-Omid TS, Ghia E, Sanchez AB, et al
     Autoantibodies against p53 are associated with chromosome 17p deletions in chronic lymphocytic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. TSUBOI K , Yokozawa T, Sakura T, Watanabe T, et al
     A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
156. NISHIOKA C , Ikezoe T, Yang J, Udaka K, et al
     Simultaneous inhibition of DNA methyltransferase and histone deacetylase induces p53-independent apoptosis via down-regulation of Mcl-1 in acute myelogenous leukemia cells.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. KUMAR AR , Yao Q, Li Q, Sam TA, et al
     Authors' comments: t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL.
     Leuk Res. 2011;35:697.
     PubMed     Text format     Related articles   
     
     
     
     
158. CHANG CS , Lee K, Yang YH, Lin MT, et al
     Estimation of CML incidence: disagreement between national cancer registry and health claims data system in Taiwan.
     Leuk Res. 2011;35:e53-4.
     PubMed     Text format     Related articles   
     
     
     
     
159. SUKHAI MA , Thomas M, Hamadanizadeh SA, Xuan Y, et al
     Correlation among nuclear localization of NuMA-RARalpha, deregulation of gene expression and leukemic phenotype of hCG-NuMA-RARalpha transgenic mice.
     Leuk Res. 2011;35:670-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. LIESVELD JL
     CML: Defining the efficacy of targeted therapy with the TARGET system.
     Leuk Res. 2011;35:575-6.
     PubMed     Text format     Related articles   
     
     
     
     
161. BRUGAT T , Nguyen-Khac F, Merle-Beral H, Delic J, et al
     Concomitant telomere shortening, acquisition of multiple chromosomal aberrations and in vitro resistance to apoptosis in a single case of progressive CLL.
     Leuk Res. 2011;35:e37-40.
     PubMed     Text format     Related articles   
     
     
     
     
162. TICKENBROCK L , Klein HU, Trento C, Hascher A, et al
     Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival.
     Leuk Res. 2011;35:620-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2011
163. UHRMACHER S , Schmidt C, Erdfelder F, Poll-Wolbeck SJ, et al
     Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
164. LIM G , Cho EH, Cho SY, Shin SY, et al
     A novel PML-ADAMTS17-RARA gene rearrangement in a patient with pregnancy-related acute promyelocytic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
165. BROBEIL A , Bobrich M, Graf M, Kruchten A, et al
     PTPIP51 is phosphorylated by Lyn and c-Src kinases lacking dephosphorylation by PTP1B in acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
166. LOPOTOVA T , Zackova M, Klamova H, Moravcova J, et al
     MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
167. DUARTE RF , Arnan M, Sanchez-Ortega I, de Llano MP, et al
     Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
168. VASKOVA M , Kovac M, Volna P, Angelisova P, et al
     High expression of cytoskeletal protein drebrin in TEL/AML1(pos) B-cell precursor acute lymphoblastic leukemia identified by a novel monoclonal antibody.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. CLARKE S , O'Reilly J, Romeo G, Cooney J, et al
     NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
170. GARCIA-PEREZ AI , Galeano E, Nieto E, Sancho P, et al
     Dequalinium induces human leukemia cell death by affecting the redox balance.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. KOTECHA RS , Murch A, Kees U, Cole CH, et al
     Pre-natal, clonal origin of t(1;11)(p32;q23) acute lymphoblastic leukemia in monozygotic twins.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. CICCONI L , Madeo G, Ramadam SM, Forte V, et al
     Transient ischemic attack as initial manifestation of acute promyelocytic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
173. HUMBERT M , Halter V, Shan D, Laedrach J, et al
     Deregulated expression of Kruppel-like factors in acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. ZHANG X , Inukai T, Akahane K, Hirose K, et al
     Endoplasmic reticulum stress inducers, but not imatinib, sensitize Philadelphia chromosome-positive leukemia cells to TRAIL-mediated apoptosis.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. YUNG E , Sekulovic S, Argiropoulos B, Lai CK, et al
     Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions.
     Leuk Res. 2011;35:545-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. PETRONELLI A , Pelosi E, Santoro S, Saulle E, et al
     CDDO-Im is a stimulator of megakaryocytic differentiation.
     Leuk Res. 2011;35:534-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. MA W , Kantarjian H, Zhang X, Wang X, et al
     Ubiquitin-proteasome system profiling in acute leukemias and its clinical relevance.
     Leuk Res. 2011;35:526-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2011
178. MARCHESI F , Lepanto D, Annibali O, Cerchiara E, et al
     Sytemic strongyloidiasis and primary aspergillosis of digestive tract in a patient with T-cell acute lymphoblastic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
179. IACOBUCCI I , Sazzini M, Garagnani P, Ferrari A, et al
     A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. TEMAN CJ , Tripp SR, Perkins SL, Duncavage EJ, et al
     Merkel cell polyomavirus (MCPyV) in chronic lymphocytic leukemia/small lymphocytic lymphoma.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. GOUGOUNON A , Abahssain H, Rigollet L, Elhamri M, et al
     Minimally differentiated acute myeloid leukemia (FAB AML-M0): Prognostic factors and treatment effects on survival-A retrospective study of 42 adult cases.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. ALJURF M , Saleh AJ, Ahmed SO
     MLL gene in maternal and infantile acute lymphoblastic leukemia and the effect of Estrogen.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
183. DUBOVSKY JA , Powers JJ, Gao Y, Mariusso LF, et al
     Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2'-deoxycytidine.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
184. TRBUSEK M , Malcikova J, Mayer J
     Selection of new TP53 mutations by therapy in chronic lymphocytic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
185. AKIYAMA M , Kawano T, Mikami-Terao Y, Agawa-Ohta M, et al
     Erythropoietin activates telomerase through transcriptional and posttranscriptional regulation in human erythroleukemic JAS-REN-A cells.
     Leuk Res. 2011;35:416-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
186. WHITTLE AM , Allsup DJ, Bailey JR
     Chronic lymphocytic leukaemia is a risk factor for venous thromboembolism.
     Leuk Res. 2011;35:419-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
187. KLAUS M , Psaraki A, Mastrodemou S, Pyrovolaki K, et al
     Evaluation of TET2 deletions in myeloid disorders: a fluorescence in situ hybridization analysis of 109 cases.
     Leuk Res. 2011;35:413-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
188. WEI A , Teh TC
     Salvaging AML with CLAG: novel option, or more of the same?
     Leuk Res. 2011;35:297-8.
     PubMed     Text format     Related articles   
     
     
     
     
189. SANDERS DS , Muntean AG, Hess JL
     Significance of AF4-MLL reciprocal fusion in t(4;11) leukemias?
     Leuk Res. 2011;35:299-300.
     PubMed     Text format     Related articles   
     
     
     
     February 2011
190. LUO Y , Zhao Y, Tan Y, Shi J, et al
     Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
191. RAVELLA PM , Liu D, Kojima K, Weisberger J, et al
     Acute promyelocytic leukemia with tetraploid karyotype: First report in the Western hemisphere and update of previous reports.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
192. DE LEEUW DC , van den Ancker W, Westers TM, Loonen AH, et al
     Challenging diagnosis in a patient with clear lymphoid immunohistochemical features and myeloid morphology: Mixed phenotype acute leukemia with erythrophagocytosis.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
193. KOTKOWSKA A , Wawrzyniak E, Blonski JZ, Robak T, et al
     Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent: Comparison with FISH.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
194. SOARES-VENTURA EM , Mkrtchyan H, de Jesus Marques-Salles T, Silva M, et al
     Molecular cytogenetics reveals complex karyotype in apparent t(8;13) therapy-related acute myeloid leukemia M2 after fibrosarcoma.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
195. PISTOIA V , Raffaghello L
     Disclosing the mysteries of the central nervous system sanctuary for acute lymphoblastic leukemia cells.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
196. ZHANG Y , Wei H, Wang M, Huai L, et al
     Some novel features of IDH1-mutated acute myeloid leukemia revealed in Chinese patients.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
197. AKERS LJ , Fang W, Levy AG, Franklin AR, et al
     Targeting glycolysis in leukemia: A novel inhibitor 3-BrOP in combination with rapamycin.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
198. BRECCIA M , Santopietro M, Cannella L, Federico V, et al
     Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
199. MEHTA DR , Foon KA, Redner RL, Raptis A, et al
     Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
200. HU J , Lin M, Liu T, Li J, et al
     DIGE-based proteomic analysis identifies nucleophosmin/B23 and nucleolin C23 as over-expressed proteins in relapsed/refractory acute leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
201. SHARMA SK , Mishra P, Seth T, Mahapatra M, et al
     Ileal ulceration during all-trans-retinoic acid therapy for acute promyelocytic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
202. LIU L , Yang L, Mi Y, Wang J, et al
     RAD51 and XRCC3 polymorphisms: Impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFbeta-MYH11(+) acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
203. HU Y , Zhang L, Wu R, Han R, et al
     Specific killing of CCR9 high-expressing acute T lymphocytic leukemia cells by CCL25 fused with PE38 toxin.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
204. FILHO RJ , de Carvalho Portela N, Neto AM, Teixeira Henderson MN, et al
     Nontuberculous mycobacterium genital infection mimicking donovanosis in a patient with hairy cell leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
205. BORZE I , Guled M, Musse S, Raunio A, et al
     MicroRNA microarrays on archive bone marrow core biopsies of leukemias--method validation.
     Leuk Res. 2011;35:188-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
206. YUAN X , Zhang Y, Zhang H, Jin J, et al
     Activity of the potent dual Abl/Src tyrosine kinase inhibitor FB2 against Bcr-Abl positive cell lines in vitro and in vivo.
     Leuk Res. 2011;35:237-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
207. YIN B
     Focal adhesion kinase comes into focus for B-cell acute lymphoblastic leukemia treatment.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
208. AMREIN L , Davidson D, Shawi M, Petruccelli L, et al
     Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
209. MANDAL SS
     Metallo-salen complexes show promise towards treatment of leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
210. ISHIKAWA Y , Kiyoi H, Naoe T
     Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
211. WANG W , Li X, Hou J, Zhou J, et al
     Coexistence of meningeal infiltration and multiple lymphadenopathy as the initial presentation of de novo adult acute megakaryoblastic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
212. TAZI I , Nafil H, Mahmal L, Elomrani A, et al
     A case of therapy-related acute lymphoblastic leukemia with t(9;22)(q34;q11.2) following treatment of breast cancer.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
213. WANG Z , Xu W, Liu L, Ding Z, et al
     The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
214. WEN Q , Hu Y, Zhang X, Kong P, et al
     Gene expression signature of lymphocyte in acute lymphoblastic leukemia patients immediately after total body irradiation.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
215. ONO T , Miyawaki S, Kimura F, Kanamori H, et al
     BCR-ABL1 mutations in patients with imatinib-resistant Philadelphia chromosome-positive leukemia by use of the PCR-Invader assay.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
216. DEEREN D
     Treatment of invasive aspergillosis with nonmyeloablative allogeneic stem cell transplantation: One stone two birds.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
217. HAENISCH B , Bonisch H, Cichon S, Allam JP, et al
     Effects of exogenous agmatine in human leukemia HMC-1 and HL-60 cells on proliferation, polyamine metabolism and cell cycle.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
218. BRECCIA M , Cannella L, Latagliata R, Nanni M, et al
     Sudden acute leukemia transformation in a MDS patient with del(5q) in complete cytogenetic remission after lenalidomide.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
219. NISHIHORI T , Fernandez HF, Coppola D, Ochoa-Bayona JL, et al
     Hepatobiliary manifestations of acute myeloid leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
220. PEKOVA S , Mazal O, Cmejla R, Hardekopf DW, et al
     A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
221. MCCORMACK SE , Cao Q, Oran B, Weisdorf DJ, et al
     Pre-transplant consolidation chemotherapy may not improve outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
222. XU W , Wang YH, Fan L, Fang C, et al
     Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia.
     Leuk Res. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
223. ESTABRAGH ZR , Knight K, Watmough SJ, Lane S, et al
     A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib.
     Leuk Res. 2011;35:49-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
224. TIRIBELLI M , Medeot M
     Cardiotoxicity of imatinib: At the heart of the problem.
     Leuk Res. 2011;35:36-7.
     PubMed     Text format     Related articles   
     
     
     
     
225. KRAUSE G , Hallek M
     On the assessment of dasatinib-induced autophagy in CLL.
     Leuk Res. 2011;35:137-8.
     PubMed     Text format     Related articles   
     
     
     
     
226. KIM MS , Chung NG, Yoo NJ, Lee SH, et al
     No mutation in the FOXP3 gene in acute leukemias.
     Leuk Res. 2011;35:e10.
     PubMed     Text format     Related articles   
     
     
     
     
227. PARK SW , Chung NG, Eom HS, Yoo NJ, et al
     Mutational analysis of EZH2 codon 641 in non-Hodgkin lymphomas and leukemias.
     Leuk Res. 2011;35:e6-7.
     PubMed     Text format     Related articles   
     
     
     
     
228. CHEN Y
     Are SRC family kinases responsible for imatinib- and dasatinib-resistant chronic myeloid leukemias?
     Leuk Res. 2011;35:27-9.
     PubMed     Text format     Related articles   
     
     
     
     
229. PITINI VV
     The role of p53 and autophagy in Dasatinib resistance of CLL lymphocytes.
     Leuk Res. 2011;35:32-3.
     PubMed     Text format     Related articles   
     
     
     
     
230. BROWN NL , Finnon R, Bulman RA, Finnon P, et al
     Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription.
     Leuk Res. 2011;35:126-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
231. NICOLINI FE , Hayette S, Legros L, Rousselot P, et al
     Pegylated IFN-alpha2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone.
     Leuk Res. 2011;35:80-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
232. AMREIN L , Soulieres D, Johnston JB, Aloyz R, et al
     p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes.
     Leuk Res. 2011;35:99-102.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
233. RAYNAL NJ , Momparler LF, Rivard GE, Momparler RL, et al
     3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
     Leuk Res. 2011;35:110-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
234. MAFFIOLI M , Camos M, Gaya A, Hernandez-Boluda JC, et al
     Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
235. DYER MJ , Majid A, Walewska R, Gesk S, et al
     Splenic infarction associated with rapidly progressive chronic lymphocytic leukemia with complex karyotype and ATM mutation.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
236. DEEB G , Vaughan MM, McInnis I, Ford LA, et al
     Hypoxia-inducible factor-1alpha protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
237. KIM MS , Yoo NJ, Lee SH
     Very low mutation frequency of exons 5-9 in the CARD11 gene from 186 adult acute leukemia and 31 multiple myeloma samples.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
238. NIU J , Li H, Zhang Y, Li J, et al
     Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
239. VOELKL A , Flaig M, Roehnisch T, Alpay N, et al
     Blastic plasmacytoid dendritic cell neoplasm with acute myeloid leukemia successfully treated to a remission currently of 26 months duration.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
240. FIEGL M , Spiekermann K
     Hypoxia and expression of hypoxia-related proteins in acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
241. HE Q , Dong J, Zhen H, Ying Y, et al
     A small molecule significantly inhibits the bcr/abl fusion gene at the mRNA level in human chronic myelogenous leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
242. HUTTER G , Kaiser M, Neumann M, Mossner M, et al
     Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
243. PARK BG , Chi HS, Jang S, Park CJ, et al
     Clonal evolution of NPM1 gene mutation in relapsed normal karyotype acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
244. LIU Y , Wang Z, Jiang M, Dai L, et al
     The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
245. JENKINS C , Hewamana S, Krige D, Pepper C, et al
     Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
246. TAUCHI T , Kizaki M, Okamoto S, Tanaka H, et al
     Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
247. DEAU B , Nicolini FE, Guilhot J, Huguet F, et al
     The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study).
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
248. FESLER MJ
     Marked bone marrow hypoplasia associated with sorafenib-induced marrow blast clearance in two patients with FLT3-ITD acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
249. LEE SY , Hille A, Kitanovic I, Jesse P, et al
     [Fe(III)(salophene)Cl], a potent iron salophene complex overcomes multiple drug resistance in lymphoma and leukemia cells.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
250. ZHU DX , Miao KR, Fang C, Fan L, et al
     Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
251. WANG Y , Li W, Chen S, Qiu H, et al
     Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21).
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
252. YAMAMOTO K , Shimoyama M, Katayama Y, Matsui T, et al
     Unbalanced whole-arm translocation der(18;21)(q10;q10) is a recurrent cytogenetic aberration appearing during progression in myeloid leukemias.
     Leuk Res. 2010;34:e339-41.
     PubMed     Text format     Related articles   
     
     
     
     
253. PAYDAS S
     Smudge cells: very old history and new conclusions.
     Leuk Res. 2010;34:1680.
     PubMed     Text format     Related articles   
     
     
     
     
254. AWIDI A , Ayed AO, Bsoul N, Magablah A, et al
     Relationship of serum imatinib trough level and response in CML patients: long term follow-up.
     Leuk Res. 2010;34:1573-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
255. DIAKOS C , Kager L
     Old drug--new insights--better treatment?
     Leuk Res. 2010;34:1558-9.
     PubMed     Text format     Related articles   
     
     
     
     
256. VAN DEN BROEKE A , Oumouna M, Beskorwayne T, Szynal M, et al
     Cytotoxic responses to BLV tax oncoprotein do not prevent leukemogenesis in sheep.
     Leuk Res. 2010;34:1663-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
257. PRICE SL , Lancet JE, George TJ, Wetzstein GA, et al
     Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
258. PRONTERA P , Pantaleoni F, Martinelli S, Mastrodicasa E, et al
     Germline PTPN11 mutation affecting exon 8 in a case of syndromic juvenile myelomonocytic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
259. YAO DM , Qian J, Lin J, Wang YL, et al
     Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
260. ELIASSON L , Clifford S, Barber N, Marin D, et al
     Exploring chronic myeloid leukemia patients' reasons for not adhering to the oral anticancer drug imatinib as prescribed.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
261. SORA F , Chiusolo P, Metafuni E, Bellesi S, et al
     Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
262. JANSSON J , Hsu YC, Kuzin II, Campbell A, et al
     Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
263. QIAN J , Qian Z, Lin J, Yao DM, et al
     Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
264. KRINGS ROCHA C , Wendtner CM, Hallek M, Kreuzer KA, et al
     Conventional cytogenetics in chronic lymphocytic leukemia (CLL).
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
265. MARSCHALEK R
     It takes two-to-leukemia: About addictions and requirements.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
266. FRIEDRICHS B , Siegel S, Reimer R, Barsoum A, et al
     High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
267. VAN TILBURG CM , van der Velden VH, Sanders EA, Wolfs TF, et al
     Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: Impact on lymphocyte compartment composition.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
268. BARRESI V , Palumbo GA, Musso N, Consoli C, et al
     Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML.
     Leuk Res. 2010;34:1539-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
269. HIRAOKA N , Yokote T, Nakayama-Ichiyama S, Takayama A, et al
     High fever and shock induced by interferon-gamma and interleukin-6 produced by adult T-cell leukaemia/lymphoma cells.
     Leuk Res. 2010;34:e290-1.
     PubMed     Text format     Related articles   
     
     
     
     
270. NAPPER JM , Sollars VE
     17-N-Allylamino-17-demethoxygeldanamycin induces a diverse response in human acute myelogenous cells.
     Leuk Res. 2010;34:1493-500.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
271. BRUSERUD O , Reikvam H
     Heat shock protein 90 (HSP90) inhibition--from experimental to clinical studies.
     Leuk Res. 2010;34:1422-3.
     PubMed     Text format     Related articles   
     
     
     
     
272. WATANABE N , Narita M, Yamahira A, Nakamura T, et al
     Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05).
     Leuk Res. 2010;34:1517-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2010
273. DUHOUX FP , De Wilde S, Ameye G, Bahloula K, et al
     Novel variant form of t(11;22)(q23;q13)/MLL-EP300 fusion transcript in the evolution of an acute myeloid leukemia with myelodysplasia-related changes.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
274. TAKAHASHI T , Kawakami K, Mishima S, Akimoto M, et al
     Cyclopamine induces eosinophilic differentiation and upregulates CD44 expression in myeloid leukemia cells.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
275. NORKIN M , Uberti JP, Schiffer CA
     Very late recurrences of leukemia: Why does leukemia awake after many years of dormancy?
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
276. SZANKASI P , Ho AK, Bahler DW, Efimova O, et al
     Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
277. LONNERHOLM G , Thorn I, Sundstrom C, Frost BM, et al
     In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
278. SANDHU I , Baumann M
     Transient marked increase in lymphocytosis during acute illness in chronic lymphocytic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
279. KHRIZMAN P , Altman JK, Mohtashamian A, Peterson L, et al
     Charcot-Leyden crystals associated with acute myeloid leukemia: Case report and literature review.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
280. KIMURA SI , Kako S, Wada H, Sakamoto K, et al
     Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia?
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
281. SHIRASAKI R , Tashiro H, Mizutani-Noguchi M, Kawasugi K, et al
     Chronic myelogenous leukemia cells convert to myofibroblasts in vitro: Effect of vascular endothelial growth factor on development of the microenvironment.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
282. COENEN EA , Zwaan CM, Meyer C, Marschalek R, et al
     KIAA1524: A novel MLL translocation partner in acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
283. AL-ACHKAR W , Wafa A, Manvelyan M, Ikhtiar A, et al
     De novo translocation involving two chromosomes in adult prolymphocytic leukemia-A rare case.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
284. BRADY MT , Lee J, Ferrone S, Wang ES, et al
     Interferon-gamma secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cells.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
285. SELVAN SR , Sheehy PF, Heinemann FS, Anbuganapathi S, et al
     Bone marrow failure due to T-cell large granular lymphocytic leukemia in a patient with essential thrombocythemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
286. FIRAT F , Ozen G, Yildiz G, Saglam A, et al
     Late relapse of acute myeloblastic leukemia as myeloid sarcoma causing radiculopathy.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
287. DEHOURS E , Riu B, Valle B, Chatelut E, et al
     Overdose with 16,000 mg of imatinib mesylate.
     Leuk Res. 2010;34:e286-7.
     PubMed     Text format     Related articles   
     
     
     
     
288. FERRARIO A , Radaelli F, Goldaniga M, F FG, et al
     ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma.
     Leuk Res. 2010;34:e280-1.
     PubMed     Text format     Related articles   
     
     
     
     
289. MACHADO RP , Queiroz JA, de Sousa JC, Goncalves RP, et al
     Is there still a role for G-banding in CLL?
     Leuk Res. 2010;34:e278-9.
     PubMed     Text format     Related articles   
     
     
     
     
290. PEDRANZINI L , Mottadelli F, Ronzoni S, Rossella F, et al
     Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment.
     Leuk Res. 2010;34:1287-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
291. ANNEREAU JP , Brel V, Dumontet C, Guminski Y, et al
     A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment.
     Leuk Res. 2010;34:1383-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
292. VALENT JN , Schiffer CA
     Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
293. D'ARENA G , Laurenti L, Minervini MM, Deaglio S, et al
     Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
294. ZAINUDDIN N , Murray F, Kanduri M, Gunnarsson R, et al
     TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
295. DUBOVSKY JA , Wang D, Powers JJ, Berchmans E, et al
     Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
296. SORIANI S , Marbello L, Colosimo A, Scarpati B, et al
     Double supernumerary isochromosome 4p in acute myelomonocytic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
297. PAPAGEORGIOU SG , Foukas P, Economopoulou C, Tsirigotis P, et al
     Acute apenditis in patient with acute promyelocytic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
298. DASANU CA , Bauer F, Alexandrescu DT
     Paraneoplastic psoriasiform dermatitis preceding the diagnosis of chronic myelogenous leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
299. BELTRAN B , Quinones P, Morales D, Cotrina E, et al
     Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
300. MORI N , Yoshinaga K, Tomita K, Ohwashi M, et al
     Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
301. GILES FJ
     Treating imatinib resistance in the few in CML-A key step towards cure in all.
     Leuk Res. 2010;34:1123-4.
     PubMed     Text format     Related articles   
     
     
     
     
302. KALLE AM , Sachchidanand S, Pallu R
     Bcr-Abl-independent mechanism of resistance to imatinib in K562 cells: Induction of cyclooxygenase-2 (COX-2) by histone deacetylases (HDACs).
     Leuk Res. 2010;34:1132-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
303. LUCENA-ARAUJO AR , de Oliveira FM, Leite-Cueva SD, Dos Santos GA, et al
     High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
304. COSTELLO RT , Sebahoun G
     Agranulocytosis occurring in a patient with chronic lymphocytic leukemia in complete remission; treatment by rituximab and cyclosporin.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
305. COYAUD E , Struski S, Dastugue N, Brousset P, et al
     PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
306. MORABITO F , Cutrona G, Gentile M, Loiacono F, et al
     More on the determination of Ki-67 as a novel potential prognostic marker in B-cell chronic lymphocytic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
307. ABDELWAHAB SI , Abdul AB, Mohan S, Taha MM, et al
     Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
308. LATAGLIATA R , Breccia M, Carmosino I, Cannella L, et al
     "Real-life" results of front-line treatment with Imatinib in older patients (>/=65 years) with newly diagnosed chronic myelogenous leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
309. LUKOV GL , Rossi L, Souroullas GP, Mao R, et al
     The expansion of T-cells and hematopoietic progenitors as a result of overexpression of the lymphoblastic leukemia gene, Lyl1 can support leukemia formation.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
310. TSUJI T , Takatsu N, Nosaka K, Kawakita T, et al
     Extramedullary tumors presenting double vision in patients with t(8;21)(q22;q22) acute myeloid leukemia lacking mutations in the receptor tyrosine kinase genes KIT or FLT3.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
311. BRADY AK , Fu AZ, Earl M, Kalaycio M, et al
     Race and intensity of post-remission therapy in acute myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
312. SEREFHANOGLU S , Buyukasik Y, Goker H, Sayinalp N, et al
     Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
313. MARCOLINO MS , Ribeiro AL, Clementino NC, Nunes MD, et al
     The use of imatinib mesylate has no adverse effects on the heart function. Results of a pilot study in patients with chronic myeloid leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
314. ZHOU GS , Hu Z, Fang HT, Zhang FX, et al
     Biologic activity of triptolide in t(8;21) acute myeloid leukemia cells.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
315. STONE RM , Moser B, Sanford B, Schulman P, et al
     High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
316. JIANG A , Jiang H, Brandwein J, Kamel-Reid S, et al
     Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
317. SARRO SM , Unruh TL, Zuccolo J, Sanyal R, et al
     Quantification of CD20 mRNA and protein levels in chronic lymphocytic leukemia suggests a post-transcriptional defect.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
318. GRIMWADE D , Tallman MS
     Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
319. HAYETTE S , Chabane K, Michallet M, Michallat E, et al
     Longitudinal studies of SRC family kinases in imatinib- and dasatinib-resistant chronic myelogenous leukemia patients.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
320. BEKSAC M , Ali R, Ozcelik T, Ozcan M, et al
     Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: Results of a randomized multicenter phase III trial.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
321. TRAKHTENBROT L , Tohami T, Schiby G, Kneller A, et al
     Post-essential thrombocythemia myelofibrosis and chronic myelomonocytic leukemia can co-exist with complex cytogenetic abnormalities.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
322. YANG L , Liu H, Zhao J, Da W, et al
     Mutations of perforin gene in Chinese patients with acute lymphoblastic leukemia.
     Leuk Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
323. MORIMOTO M , Kondoh K, Keino D, Ohyama R, et al
     A child with myeloid/natural killer cell precursor acute leukemia treated successfully with acute myeloid leukemia-oriented chemotherapy incorporating l-asparaginase.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     June 2010
324. ANTHONY N , Shanks J, Terebelo H
     Occurrences of opportunistic infections in chronic myelogenous leukemia patients treated with imatinib mesylate.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
325. WINKLER J , Rech D, Kallert S, Rech J, et al
     Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: A case report.
     Leuk Res. 2010.
     PubMed     Text format     Related articles   
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: